News  

Startup Renovion, its marketing slogan “Restoring Lung Health One Breath at a Time,” has gotten two doses of fresh air for its treatment eff

Renovion today announced that Dr. Martin “Marty” Zamora, MD, has joined Renovion as Chief Medical Officer. Dr. Zamora will lead the Phase...

Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...

Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...

Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the development of a novel therapy for...

Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the...

Poised for pivotal lung transplant trial in U.S. Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of...

Renovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for respiratory diseases, including lung...

Renovion, Inc. ("Renovion"), an early stage drug development company targeting a novel treatment for lung transplant patients and other...

Two Chapel Hill-based startups — EpiCypher and Renovion — attended the first University Startups Demo Day in Washington, D.C. On Tuesday,...

Of the more than 800 startups created at universities across the country this year, only 35 have been handpicked as the best and earned...

In a tiny lab in Chapel Hill, a 3-year-old startup with UNC-Chapel Hill technology is trying to help lung transplant patients defy the...

- Patent claims set foundation for commercialization - Board and management team in place to execute pre-clinical plan CHAPEL HILL, N.C.,...